These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3018537)

  • 1. Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants.
    Franke CA; Rice CM; Strauss JH; Hruby DE
    Mol Cell Biol; 1985 Aug; 5(8):1918-24. PubMed ID: 3018537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 35-kilodalton protein gene (p35) of Autographa californica nuclear polyhedrosis virus and the neomycin resistance gene provide dominant selection of recombinant baculoviruses.
    Lerch RA; Friesen PD
    Nucleic Acids Res; 1993 Apr; 21(8):1753-60. PubMed ID: 8493093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BiZyme: a novel fusion protein-mediating selection of vaccinia virus recombinants by fluorescence and antibiotic resistance.
    Hansen SG; Cope TA; Hruby DE
    Biotechniques; 2002 May; 32(5):1178, 1180, 1182-7. PubMed ID: 12019792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNA.
    Weir JP; Bajszár G; Moss B
    Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1210-4. PubMed ID: 6280173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibition of vaccinia virus growth by 2'-O-methyladenosine: isolation of a drug-resistant virus mutant.
    Raczynski P; Condit RC
    Virology; 1983 Jul; 128(2):458-62. PubMed ID: 6412452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.
    Mackett M; Smith GL; Moss B
    J Virol; 1984 Mar; 49(3):857-64. PubMed ID: 6321770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plaque size phenotype as a selectable marker to generate vaccinia virus recombinants.
    Rodriguez JF; Esteban M
    J Virol; 1989 Feb; 63(2):997-1001. PubMed ID: 2911129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and expression of foreign genes in vaccinia virus, using a host range selection system.
    Perkus ME; Limbach K; Paoletti E
    J Virol; 1989 Sep; 63(9):3829-36. PubMed ID: 2547999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Puromycin resistance (pac) gene as a selectable marker in vaccinia virus.
    Sánchez-Puig JM; Blasco R
    Gene; 2000 Oct; 257(1):57-65. PubMed ID: 11054568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable transformation of Drosophila Kc cells to antibiotic resistance with the bacterial neomycin resistance gene.
    Maisonhaute C; Echalier G
    FEBS Lett; 1986 Mar; 197(1-2):45-9. PubMed ID: 3005047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host range selection of vaccinia recombinants containing insertions of foreign genes into non-coding sequences.
    Smith KA; Stallard V; Roos JM; Hart C; Cormier N; Cohen LK; Roberts BE; Payne LG
    Vaccine; 1993; 11(1):43-53. PubMed ID: 8427036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant host range selection of vaccinia recombinants by rescue of an essential gene.
    Holzer GW; Gritschenberger W; Mayrhofer JA; Wieser V; Dorner F; Falkner FG
    Virology; 1998 Sep; 249(1):160-6. PubMed ID: 9740787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficient method for generating poxvirus recombinants in the absence of selection.
    Rice AD; Gray SA; Li Y; Damon I; Moyer RW
    Viruses; 2011 Mar; 3(3):217-32. PubMed ID: 21494427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aphidicolin on vaccinia virus: isolation of an aphidicolin-resistant mutant.
    DeFilippes FM
    J Virol; 1984 Nov; 52(2):474-82. PubMed ID: 6436508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transduction of cellular neo mRNA by retrovirus-mediated recombination.
    Stuhlmann H; Dieckmann M; Berg P
    J Virol; 1990 Dec; 64(12):5783-96. PubMed ID: 1700824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter.
    Hermonat PL; Santin AD; De Greve J; De Rijcke M; Bishop BM; Han L; Mane M; Kokorina N
    J Hum Virol; 1999; 2(6):359-68. PubMed ID: 10774553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graduated resistance to G418 leads to differential selection of cultured mammalian cells expressing the neo gene.
    Paludan K; Duch M; Jørgensen P; Kjeldgaard NO; Pedersen FS
    Gene; 1989 Dec; 85(2):421-6. PubMed ID: 2560757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.
    Southern PJ; Berg P
    J Mol Appl Genet; 1982; 1(4):327-41. PubMed ID: 6286831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination.
    Wolffe EJ; Isaacs SN; Moss B
    J Virol; 1993 Aug; 67(8):4732-41. PubMed ID: 8331727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dominant selectable marker for the construction of recombinant poxviruses.
    Boyle DB; Coupar BE
    Gene; 1988 May; 65(1):123-8. PubMed ID: 2840353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.